prescribing guide semaglutide tirzepatide December Blog Post: Tirzepatide, Worth the Weight? Semaglutide vs Tirzepatide Weight Loss

In a large retrospective cohort study including over 1.6 million patients with Type 2 Diabetes, with no prior diagnosis of obesity associated cancers, a significantly reduced risk in 10 out of 13 obesity associated cancers was reported with the use of GLP-1 agonists, including esophageal, colorectal, endometrial, gallbladder, kidney, liver, ovarian, pancreatic cancer, meningioma, and multiple myeloma 17

sales, reported in millions

The healthcare technological appraisal, governmental strategies, the proactive formulary inclusion of weight management, an expansion in accessible volumes, and premium-priced next-generation therapies are certain trends that are boosting the semaglutide market in the UK

Wherever you're listening right now, if I can ask you to just take 30 seconds, leave me a review

In the present study, we investigated whether uric acid could induce the production of IL-1 in its soluble form

doi: 10.2741/S415, 3